{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:19:26Z","timestamp":1790965166649,"version":"4.1.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"Supplement_7","license":[{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01AI102887-01A1"],"award-info":[{"award-number":["1R01AI102887-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Ebolaviruses Ebola (EBOV), Sudan (SUDV), and Bundibugyo (BDBV) cause severe human disease, which may be accompanied by hemorrhagic syndrome, with high case fatality rates. Monovalent vaccines do not offer cross-protection against these viruses whose endemic areas overlap. Therefore, development of a panebolavirus vaccine is a priority. As a vaccine vector, human parainfluenza virus type 3 (HPIV3) has the advantages of needle-free administration and induction of both systemic and local mucosal antibody responses in the respiratory tract.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To minimize the antivector immunity, genes encoding the HPIV3 envelope proteins F and HN were removed from the vaccine constructs, resulting in expression of only the ebolavirus envelope protein\u2014glycoprotein. These second-generation vaccine constructs were used to develop a combination vaccine against EBOV, SUDV, and BDBV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A single intranasal vaccination of guinea pigs or ferrets with the trivalent combination vaccine elicited humoral responses to each of the targeted ebolaviruses, including binding and neutralizing antibodies, as well as Fc-mediated effector functions. This vaccine protected animals from death and disease caused by lethal challenges with EBOV, SUDV, or BDBV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The combination vaccine elicited protection that was comparable to that induced by the monovalent vaccines, thus demonstrating the value of this combination trivalent vaccine.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/infdis\/jiad266","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T03:19:37Z","timestamp":1689823177000},"page":"S648-S659","source":"Crossref","is-referenced-by-count":10,"title":["A Single-Dose Intranasal Combination Panebolavirus Vaccine"],"prefix":"10.1093","volume":"228","author":[{"given":"Delphine C","family":"Malherbe","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Texas Medical Branch , Galveston, Texas , USA"},{"name":"Galveston National Laboratory , Galveston, Texas , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Brian","family":"Kimble","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Texas Medical Branch , Galveston, Texas , USA"},{"name":"Galveston National Laboratory , Galveston, Texas , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Atyeo","sequence":"additional","affiliation":[{"name":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard , Cambridge, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Fischinger","sequence":"additional","affiliation":[{"name":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard , Cambridge, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Meyer","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Texas Medical Branch , Galveston, Texas , USA"},{"name":"Galveston National Laboratory , Galveston, Texas , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S Gabrielle","family":"Cody","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Texas Medical Branch , Galveston, Texas , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hyde","sequence":"additional","affiliation":[{"name":"Galveston National Laboratory , Galveston, Texas , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galit","family":"Alter","sequence":"additional","affiliation":[{"name":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard , Cambridge, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0342-4824","authenticated-orcid":false,"given":"Alexander","family":"Bukreyev","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Texas Medical Branch , Galveston, Texas , USA"},{"name":"Galveston National Laboratory , Galveston, Texas , USA"},{"name":"Department of Microbiology and Immunology, University of Texas Medical Branch , Galveston, Texas , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"key":"2023111521043053200_jiad266-B1","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","article-title":"Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses","volume":"11","author":"Jones","year":"2005","journal-title":"Nat Med"},{"key":"2023111521043053200_jiad266-B2","author":"Centers for Disease Control and Prevention"},{"key":"2023111521043053200_jiad266-B3","author":"World Health Organization","year":"2020"},{"key":"2023111521043053200_jiad266-B4","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1128\/JVI.80.5.2267-2279.2006","article-title":"A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challenge","volume":"80","author":"Bukreyev","year":"2006","journal-title":"J Virol"},{"key":"2023111521043053200_jiad266-B5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.virol.2008.04.029","article-title":"A paramyxovirus-vectored intranasal vaccine against Ebola virus is immunogenic in vector-immune animals","volume":"377","author":"Yang","year":"2008","journal-title":"Virology"},{"key":"2023111521043053200_jiad266-B6","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.celrep.2018.07.044","article-title":"Antibody repertoires to the same Ebola vaccine antigen are differentially affected by vaccine vectors","volume":"24","author":"Meyer","year":"2018","journal-title":"Cell Rep"},{"key":"2023111521043053200_jiad266-B7","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1128\/JVI.00105-07","article-title":"Successful topical respiratory tract immunization of primates against Ebola virus","volume":"81","author":"Bukreyev","year":"2007","journal-title":"J Virol"},{"key":"2023111521043053200_jiad266-B8","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1172\/JCI81532","article-title":"Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responses","volume":"125","author":"Meyer","year":"2015","journal-title":"J Clin Invest"},{"key":"2023111521043053200_jiad266-B9","doi-asserted-by":"crossref","first-page":"eabg6128","DOI":"10.1126\/scitranslmed.abg6128","article-title":"Ebola vaccine-induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effects","volume":"13","author":"Meyer","year":"2021","journal-title":"Sci Transl Med"},{"key":"2023111521043053200_jiad266-B10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.virol.2008.09.030","article-title":"Chimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challenge","volume":"383","author":"Bukreyev","year":"2009","journal-title":"Virology"},{"key":"2023111521043053200_jiad266-B11","doi-asserted-by":"crossref","first-page":"e01845-18","DOI":"10.1128\/JVI.01845-18","article-title":"Antibody-mediated protective mechanisms induced by a trivalent parainfluenza virus-vectored ebolavirus vaccine","volume":"93","author":"Kimble","year":"2019","journal-title":"J Virol"},{"key":"2023111521043053200_jiad266-B12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41541-022-00512-x","article-title":"A single immunization with a modified vaccinia Ankara vectored vaccine producing Sudan virus-like particles protects from lethal infection","volume":"7","author":"Malherbe","year":"2022","journal-title":"NPJ Vaccines"},{"key":"2023111521043053200_jiad266-B13","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.1086\/514305","article-title":"Pathogenesis of experimental Ebola virus infection in guinea pigs","volume":"179","author":"Connolly","year":"1999","journal-title":"J Infect Dis"},{"key":"2023111521043053200_jiad266-B14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1128\/JVI.02331-15","article-title":"Development and characterization of a guinea pig-adapted Sudan virus","volume":"90","author":"Wong","year":"2015","journal-title":"J Virol"},{"key":"2023111521043053200_jiad266-B15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.virol.2004.10.048","article-title":"Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening","volume":"332","author":"Towner","year":"2005","journal-title":"Virology"},{"key":"2023111521043053200_jiad266-B16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.virusres.2005.03.028","article-title":"Complete genome sequence of an Ebola virus (Sudan species) responsible for a 2000 outbreak of human disease in Uganda","volume":"113","author":"Sanchez","year":"2005","journal-title":"Virus Res"},{"key":"2023111521043053200_jiad266-B17","doi-asserted-by":"crossref","first-page":"e1000212","DOI":"10.1371\/journal.ppat.1000212","article-title":"Newly discovered Ebola virus associated with hemorrhagic fever outbreak in Uganda","volume":"4","author":"Towner","year":"2008","journal-title":"PLoS Pathog"},{"key":"2023111521043053200_jiad266-B18","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4172\/2576-1420.1000102","article-title":"Identification of a guinea pig Fcgamma receptor that exhibits enhanced binding to afucosylated human and mouse IgG","volume":"1","author":"Mao","year":"2017","journal-title":"J Infect Dis Med"},{"key":"2023111521043053200_jiad266-B19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0147-9571(82)90074-1","article-title":"Heterogeneity of human lymphocyte Fc receptors: studies using heat-aggregated and antigen-complexed IgG from human, rabbit, guinea pig, horse and goat","volume":"5","author":"Gormus","year":"1982","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"2023111521043053200_jiad266-B20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/irv.12687","article-title":"Improving immunological insights into the ferret model of human viral infectious disease","volume":"13","author":"Wong","year":"2019","journal-title":"Influenza Other Respir Viruses"},{"key":"2023111521043053200_jiad266-B21","doi-asserted-by":"crossref","first-page":"19277","DOI":"10.1074\/jbc.RA118.005294","article-title":"Comprehensive analysis of N-glycans in IgG purified from ferrets with or without influenza A virus infection","volume":"293","author":"Zou","year":"2018","journal-title":"J Biol Chem"},{"key":"2023111521043053200_jiad266-B22","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.vaccine.2020.01.008","article-title":"Activity of human serum antibodies in an influenza virus hemagglutinin stalk-based ADCC reporter assay correlates with activity in a CD107a degranulation assay","volume":"38","author":"Chromikova","year":"2020","journal-title":"Vaccine"},{"key":"2023111521043053200_jiad266-B23","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1128\/JVI.02481-15","article-title":"Hemagglutinin stalk immunity reduces influenza virus replication and transmission in ferrets","volume":"90","author":"Nachbagauer","year":"2015","journal-title":"J Virol"},{"key":"2023111521043053200_jiad266-B24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/infdis\/jiw209","article-title":"The domestic ferret (Mustela putorius furo) as a lethal infection model for 3 species of ebolavirus","volume":"214","author":"Cross","year":"2016","journal-title":"J Infect Dis"},{"key":"2023111521043053200_jiad266-B25","first-page":"996","volume-title":"Fields virology, Vol. 1","author":"Karron","year":"2013"},{"key":"2023111521043053200_jiad266-B26","first-page":"e00137","article-title":"Transmission of Ebola viruses: what we know and what we do not know","volume":"6","author":"Osterholm","year":"2015","journal-title":"mBio"},{"key":"2023111521043053200_jiad266-B27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1128\/jcm.22.2.259-264.1985","article-title":"Subclass distribution and molecular form of immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans","volume":"22","author":"Brown","year":"1985","journal-title":"J Clin Microbiol"},{"key":"2023111521043053200_jiad266-B28","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1128\/iai.41.2.540-545.1983","article-title":"Hemagglutinin-specific antibody responses in immunoglobulin G, A, and M isotypes as measured by enzyme-linked immunosorbent assay after primary or secondary infection of humans with influenza A virus","volume":"41","author":"Burlington","year":"1983","journal-title":"Infect Immun"},{"key":"2023111521043053200_jiad266-B29","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1542\/peds.23.6.1041","article-title":"Clinical trials in infants of orally administered attenuated poliomyelitis viruses","volume":"23","author":"Plotkin","year":"1959","journal-title":"Pediatrics"},{"key":"2023111521043053200_jiad266-B30","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1136\/bmj.1.5345.1573","article-title":"Response of 3-months-old infants to 3 doses of trivalent oral poliomyelitis vaccine","volume":"1","author":"Perkins","year":"1963","journal-title":"Br Med J"},{"key":"2023111521043053200_jiad266-B31","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4269\/ajtmh.2009.80.302","article-title":"Evaluation of interferences between dengue vaccine serotypes in a monkey model","volume":"80","author":"Guy","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"2023111521043053200_jiad266-B32","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/infdis\/jir279","article-title":"Interference and facilitation between dengue serotypes in a tetravalent live dengue virus vaccine candidate","volume":"204","author":"Anderson","year":"2011","journal-title":"J Infect Dis"},{"key":"2023111521043053200_jiad266-B33","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1128\/JVI.00561-09","article-title":"Single-injection vaccine protects nonhuman primates against infection with Marburg virus and three species of Ebola virus","volume":"83","author":"Geisbert","year":"2009","journal-title":"J Virol"},{"key":"2023111521043053200_jiad266-B34","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1074\/jbc.M110.163030","article-title":"Interaction of two phagocytic host defense systems: Fcgamma receptors and complement receptor 3","volume":"286","author":"Huang","year":"2011","journal-title":"J Biol Chem"},{"key":"2023111521043053200_jiad266-B35","doi-asserted-by":"crossref","first-page":"857481","DOI":"10.3389\/fimmu.2022.857481","article-title":"Complement-mediated neutralisation identified in Ebola virus disease survivor plasma: implications for protection and pathogenesis","volume":"13","author":"Mellors","year":"2022","journal-title":"Front Immunol"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiad266\/50914940\/jiad266.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/228\/Supplement_7\/S648\/53451795\/jiad266.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/228\/Supplement_7\/S648\/53451795\/jiad266.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T16:11:30Z","timestamp":1700064690000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/228\/Supplement_7\/S648\/7226717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":35,"journal-issue":{"issue":"Supplement_7","published-online":{"date-parts":[[2023,7,20]]},"published-print":{"date-parts":[[2023,11,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiad266","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,11,15]]},"published":{"date-parts":[[2023,7,20]]}}}